DE60041753D1 - Arzneimittel zur behandlung von c. pneumoniae infektionen - Google Patents

Arzneimittel zur behandlung von c. pneumoniae infektionen

Info

Publication number
DE60041753D1
DE60041753D1 DE60041753T DE60041753T DE60041753D1 DE 60041753 D1 DE60041753 D1 DE 60041753D1 DE 60041753 T DE60041753 T DE 60041753T DE 60041753 T DE60041753 T DE 60041753T DE 60041753 D1 DE60041753 D1 DE 60041753D1
Authority
DE
Germany
Prior art keywords
treatment
medicament
pneumoniae infections
prevention
atherosclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60041753T
Other languages
English (en)
Inventor
James Peter Burnie
Ruth Christine Matthews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neutec Pharma Ltd
Original Assignee
Neutec Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Ltd filed Critical Neutec Pharma Ltd
Application granted granted Critical
Publication of DE60041753D1 publication Critical patent/DE60041753D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DE60041753T 1999-02-05 2000-01-28 Arzneimittel zur behandlung von c. pneumoniae infektionen Expired - Lifetime DE60041753D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9902555.3A GB9902555D0 (en) 1999-02-05 1999-02-05 Medicament
PCT/GB2000/000237 WO2000046359A2 (en) 1999-02-05 2000-01-28 Medicament

Publications (1)

Publication Number Publication Date
DE60041753D1 true DE60041753D1 (de) 2009-04-23

Family

ID=10847149

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60041753T Expired - Lifetime DE60041753D1 (de) 1999-02-05 2000-01-28 Arzneimittel zur behandlung von c. pneumoniae infektionen

Country Status (8)

Country Link
US (1) US7132512B2 (de)
EP (1) EP1149162B1 (de)
AT (1) ATE425248T1 (de)
AU (1) AU2119200A (de)
CA (1) CA2359354C (de)
DE (1) DE60041753D1 (de)
GB (1) GB9902555D0 (de)
WO (1) WO2000046359A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1105490A1 (de) 1998-08-20 2001-06-13 Aventis Pasteur Limited Einschlussmembranprotein c von chlamydia kodierende nukleinsäuremoleküle
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
CA2340283A1 (en) 1998-08-20 2000-03-02 Aventis Pasteur Limited Nucleic acid molecules encoding pomp91a protein of chlamydia
US6649370B1 (en) 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6607730B1 (en) 1998-11-02 2003-08-19 Aventis Pasteur Limited/Aventis Pasteur Limitee Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020094340A1 (en) 1998-12-01 2002-07-18 Andrew D. Murdin Chlamydia antigens and corresponding dna thereof
JP2002531129A (ja) 1998-12-08 2002-09-24 コリクサ コーポレイション クラミジア感染の処置および診断のための化合物および方法
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7297341B1 (en) 1998-12-23 2007-11-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6808713B1 (en) 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
DE69938059T2 (de) 1998-12-28 2009-01-08 Sanofi Pasteur Ltd., Toronto Chlamydia antigene, entsprechende dna-fragmente und ihre verwendungen
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
EP2172214A3 (de) 1999-03-12 2011-03-16 Aventis Pasteur Limited Chlamydia-Antigene und entsprechende DNA-Fragmente sowie Verwendungen davon
WO2000066739A2 (en) 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
JP4667694B2 (ja) 1999-09-20 2011-04-13 サノフィ、パストゥール、リミテッド クラミジア抗原および対応するｄｎａ断片ならびにその使用
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
NZ520200A (en) 1999-12-22 2004-04-30 Aventis Pasteur Polynucleotides encoding the Clamydia pneumoniae polypeptides omp P6 precursor gene product
WO2001081379A2 (en) 2000-04-21 2001-11-01 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
EP1282718B1 (de) 2000-05-08 2006-12-20 Sanofi Pasteur Limited Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
AU2001276619A1 (en) 2000-07-03 2002-01-14 Chiron S.P.A. Immunisation against chlamydia pneumoniae
CA2447823A1 (en) * 2001-05-23 2002-11-28 The University Of British Columbia Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
DE102006003814A1 (de) * 2006-01-26 2007-08-02 Sirs-Lab Gmbh Verfahren zur in-vitro-Diagnose von Chlamydophila pneumoniae Infektionen
EP2403526B1 (de) 2009-03-06 2019-05-15 GlaxoSmithKline Biologicals SA Chlamydia-antigene
KR101297037B1 (ko) * 2010-03-26 2013-08-14 숙명여자대학교산학협력단 혈관신생촉진용 펩타이드 및 이의 용도
KR101335203B1 (ko) * 2010-03-26 2013-11-29 숙명여자대학교산학협력단 혈관신생촉진용 펩타이드 및 이의 용도

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0784059B1 (de) * 1994-09-20 2009-02-11 Hitachi Chemical Co., Ltd. Polynukleotide die einen antigenes polypeptid aus chlamydia pneumoniae kodieren
KR20010032336A (ko) * 1997-11-21 2001-04-16 브랑디 빠스깔 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
KR100735651B1 (ko) 1997-11-28 2007-07-06 세로노 제네틱스 인스티튜트 에스.에이. 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
EP1133572A4 (de) 1998-11-12 2005-06-15 Univ California Genomsequenz von chlamydia pneumoniae
JP2002531129A (ja) 1998-12-08 2002-09-24 コリクサ コーポレイション クラミジア感染の処置および診断のための化合物および方法
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
WO2000066739A2 (en) 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
JP4667694B2 (ja) 1999-09-20 2011-04-13 サノフィ、パストゥール、リミテッド クラミジア抗原および対応するｄｎａ断片ならびにその使用
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
NZ520200A (en) 1999-12-22 2004-04-30 Aventis Pasteur Polynucleotides encoding the Clamydia pneumoniae polypeptides omp P6 precursor gene product
WO2001081379A2 (en) 2000-04-21 2001-11-01 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
EP1282718B1 (de) 2000-05-08 2006-12-20 Sanofi Pasteur Limited Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
AU2001276619A1 (en) 2000-07-03 2002-01-14 Chiron S.P.A. Immunisation against chlamydia pneumoniae

Also Published As

Publication number Publication date
AU2119200A (en) 2000-08-25
WO2000046359A2 (en) 2000-08-10
WO2000046359A3 (en) 2000-12-07
CA2359354C (en) 2008-07-08
US7132512B2 (en) 2006-11-07
GB9902555D0 (en) 1999-03-24
ATE425248T1 (de) 2009-03-15
US20040029806A1 (en) 2004-02-12
EP1149162A2 (de) 2001-10-31
EP1149162B1 (de) 2009-03-11
CA2359354A1 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
SE0102315D0 (sv) Compounds
MY142948A (en) Benzophenones as inhibitors of reverse transcriptase
WO2003099110A3 (en) Herbs and herbal combinations useful for the treatment of microbial infections
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
ATE457998T1 (de) Abgeschwächte mikroorganismen für die behandlung von infektionen
ATE433963T1 (de) Fab-i inhibitoren
EE200300064A (et) Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine
DK1057828T3 (da) Orale trovafloxacin-suspensioner
WO2000058475A3 (en) Streptococcus pneumoniae antigens
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
ATE309803T1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
ATE225172T1 (de) Acylurea-verbindungen zur behandlung von coccidioidomycosis bei warmblütigen tieren
ATE241640T1 (de) Fusidinsäure-derivate
ATE357931T1 (de) Mittel zur prävention/behandlung entzündlicher darmerkrankungen
TR200003301T2 (tr) Morfolino eterler
WO2002002087A3 (de) Anthelmintika zur verhinderung von parasitären infektionen bei menschen und tieren ii
ATE299020T1 (de) Verwendung von thiamphenicol in der behandlung von infektionen verursacht durch chlamydia pneumoniae
SE9902674D0 (sv) New composition
EA200100768A1 (ru) Применение 3-изоксазолидинонов и гидроксиаминокислот для лечения инфекций
SE9902673D0 (sv) New composition
IT1304822B1 (it) Composizione anticrittogamica particolarmente idonea per trattareinfezioni fungine e batteriche delle piante.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition